Dapaglifozin in advanced heart failure patients : effects on congestion, NTproBNP and cardiorenal outcome

Back

HFA Premium Access

Dapaglifozin in advanced heart failure patients : effects on congestion, NTproBNP and cardiorenal outcome

Session: ePosters in chronic heart failure - pharmacotherapy 1

Topic: Pharmacotherapy

Speaker: Doctor G. Ruocco (Maastricht, NL)

Event: Heart Failure 2024

Congress Presentation

Add to my library

About the speaker

Doctor Gaetano Ruocco

Cardiovascular Research Institute Maastricht (CARIM), Maastricht (Netherlands (The))

0 follower

5 more presentations in this session

Decline in functional capacity is associated with reduced ability to perform activities of daily living in patients with transthyretin cardiac amyloidosis: post hoc analysis of the APOLLO-B study

Speaker: Doctor O. Lairez (Toulouse, FR)

Navigating the realms of SGLT2 inhibitors bridging clinical studies enthusiasm with practical realities

Speaker: Doctor M. ElRefai (Basildon, GB)

Heart rate management practices across the spectrum of HFrEF patient journey in Indian clinical settings

Speaker: Doctor V. Kolapkar (Mumbai, IN)

Age-related implications in guideline-directed medical therapy up-titration for heart failure with reduced ejection fraction

Speaker: Doctor J. Cravo (Lisbon, PT) Doctor C. Gregorio (Lisbon, PT)

Home intravenous diuretics: a way to reduce hospital bed usage and urgent admissions

Speaker: Doctor M. Castro (Guimaraes, PT)

Access the full session

ePosters in chronic heart failure - pharmacotherapy 1

Speakers: Doctor G. Ruocco, Doctor O. Lairez, Doctor M. ElRefai, Doctor V. Kolapkar, Doctor J. Cravo...

Access

About the event

Heart Failure 2024

11 May - 14 May 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources